TFA
VRTX icon

Toth Financial Advisory’s Vertex Pharmaceuticals VRTX Stock Holding History

Toth Financial Advisory’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$149K Sell
300
-6
-2% -$2.66K 0.01% 258
2026
Q1 		$137K Buy
306
+76
+33% +$35.4K 0.02% 249
2025
Q4 		$104K Hold
230
– – 0.01% 260
2025
Q3 		$90.1K Hold
230
– – 0.01% 278
2025
Q2 		$102K Hold
230
– – 0.01% 242
2025
Q1 		$112K Hold
230
– – 0.01% 234
2024
Q4 		$92.6K Sell
230
-1,320
-85% -$612K 0.01% 246
2024
Q3 		$721K Buy
1,550
+1,450
+1,450% +$697K 0.09% 145
2024
Q2 		$46.9K Hold
100
– – 0.01% 301
2024
Q1 		$41.8K Hold
100
– – 0.01% 309
2023
Q4 		$40.7K Hold
100
– – 0.01% 315
2023
Q3 		$34.8K Hold
100
– – 0.01% 305
2023
Q2 		$35.2K Sell
100
-39
-28% -$13.1K 0.01% 312
2023
Q1 		$43.8K Buy
139
+39
+39% +$11.7K 0.01% 289
2022
Q4 		$28.9K Hold
100
– – ﹤0.01% 340
2022
Q3 		$29K Hold
100
– – 0.01% 340
2022
Q2 		$28K Hold
100
– – ﹤0.01% 334
2022
Q1 		$26K Hold
100
– – ﹤0.01% 357
2021
Q4 		$22K Buy
100
+82
+456% +$15.9K ﹤0.01% 395
2021
Q3 		$3K Hold
18
– – ﹤0.01% 623
2021
Q2 		$4K Hold
18
– – ﹤0.01% 529
2021
Q1 		$4K Hold
18
– – ﹤0.01% 537
2020
Q4 		$4K Sell
18
-2,875
-99% -$660K ﹤0.01% 482
2020
Q3 		$787K Sell
2,893
-1,610
-36% -$444K 0.15% 110
2020
Q2 		$1.31M Buy
4,503
+443
+11% +$120K 0.28% 83
2020
Q1 		$966K Buy
4,060
+1,330
+49% +$305K 0.28% 78
2019
Q4 		$598K Buy
+2,730
New +$553K 0.12% 113
2019
Q2 		– Sell
-1,642
Closed -$302K – 478
2019
Q1 		$302K Buy
+1,642
New +$303K 0.07% 138

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return
MLL
Moody Lynn & Lieberson Boston, Massachusetts $1.9B AUM 27.82% 1-Year Est. Return

Toth Financial Advisory's VRTX Position: Q2 2026 in Review

Toth Financial Advisory reduced its Vertex Pharmaceuticals (VRTX) stake by 2% in Q2 2026, selling an estimated $2.66K and leaving 300 shares worth $149K. The position accounts for 0.01% of the portfolio, ranked #258.

Toth Financial Advisory first reported a position in VRTX in Q1 2019 and has held it in 28 quarters since. The position peaked at $1.31M in Q2 2020. 308 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • Toth Financial Advisory held 300 shares of Vertex Pharmaceuticals worth $149K as of Q2 2026.
  • Toth Financial Advisory sold 6 Vertex Pharmaceuticals shares in Q2 2026, an estimated $2.66K.
  • Vertex Pharmaceuticals made up 0.01% of Toth Financial Advisory's portfolio in Q2 2026, its #258 holding.
  • Toth Financial Advisory first reported a position in Vertex Pharmaceuticals in Q1 2019 and has held it in 28 quarters since.
  • Toth Financial Advisory's Vertex Pharmaceuticals position peaked at $1.31M in Q2 2020.
  • 308 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Toth Financial Advisory's 13F filing for Q2 2026, filed 14 Jul 2026.